RecruitingNot ApplicableNCT06294613

Study of the ACUSURGICAL Luca System for Treatment of Vitreoretinal Diseases

A Prospective, Open-label, Multi-center, Study of the ACUSURGICAL Luca System for Treatment of Vitreoretinal Diseases

Sponsor

Acusurgical

Enrollment

15 participants

Start Date

Feb 8, 2024

Study Type

INTERVENTIONAL

Conditions

Vitreoretinal Disease

Summary

Prospective, interventional, open-label, non-controlled, multicentric study in Belgium of Luca, of up to 15 evaluable subjects, undergoing vitreoretinal surgery to treat intravitreal hemorrhage and macular pucker. Only one eye per subject can be enrolled.

Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called vitreoretinal surgery for people with vitreoretinal disease. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEvitreoretinal surgery

Patients undergoing vitreoretinal surgery

Locations(2)

UZ Gent

Ghent, East Flanders, Belgium

Delta Hospital - CHIREC (Centre Hospitalier Interrégional Edith Cavell)

Brussels, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06294613

Related Trials

Metabolomic Profile of Vitreoretinal Diseases: an NMR-Based Approach Using Vitreous.

NCT064299691 location